Clinical Trial Update: Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer

View source ↗

Summary

A clinical trial evaluating circulating tumor DNA in HER2-low advanced/metastatic breast cancer is currently recruiting. Sponsor: European Institute of Oncology…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Advanced Metastatic Breast Cancer | Status: RECRUITING